Association of retinol-binding protein-4 (RBP4) with lipid parameters in obese women.

CIBER (CB06/03) Fisiopatologia de la Obesidad y Nutrición, Instituto de Salud Carlos III, Madrid, Spain.
Obesity Surgery (Impact Factor: 3.74). 09/2010; 20(9):1258-64. DOI: 10.1007/s11695-010-0200-5
Source: PubMed

ABSTRACT Although the adipokine retinol-binding protein-4 (RBP4) has been implicated in the development of obesity-related insulin resistance, its role in human obesity is still unclear. Our objectives were to find out the effect on RBP4 systemic levels of a weight loss induced by gastric bypass surgery and to analyze RBP4 relationships with insulin resistance, parameters of body composition, lipid metabolism, and inflammation.
Sixty-three obese women were analyzed before and 12 months after surgery of systemic concentrations of RBP4, fasting glucose, insulin, lipid profile molecules, and inflammation-related proteins (C-reactive protein, tumor necrosis factor-alpha receptors 1 and 2, interleukin-18, and adiponectin), and waist and hip circumference measurements, body mass index calculation, and insulin resistance index by homeostasis model assessment were also made.
We found that RBP4 levels were lower after weight reduction by gastric bypass surgery (p < 0.0001). We found RBP4 associated with triglycerides before (beta = 0.37, p = 0.02) and after surgery (beta = 0.59, p < 0.0001) and negatively with weight loss after surgery (beta = -0.37, p = 0.003). When expressed as a percentage of change, the decrease of RBP4 was related to the reduction in the levels of triglycerides and with the increase in HDL-cholesterol (beta = 0.73, p = 0.02 and beta = 0.62, p = 0.04, respectively). Others parameters analyzed, including inflammatory markers, were not related to RBP4.
This study shows that, in obese women and after a substantial weight loss due to bariatric surgery, RBP4 was related to weight status and lipid parameters rather than to insulin sensitivity or inflammatory markers.


Available from: Iñaki I Elío, Jun 03, 2015
  • Journal of Medical Biochemistry 01/2012; 31(1). DOI:10.2478/v10011-011-0032-4 · 1.08 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Obesity is currently a worldwide public health problem. Retinol-binding protein4 (RBP4) is a recently discovered adipokine, which is potentially associated with insulin resistance and obesity. We aimed to investigate whether genetic variation within the RBP4 gene is correlated with the obesity and lipid profile in Iranian population. 321 samples were randomly selected from participants of Isfahan healthy heart program (IHHP). Genomic DNA was isolated from peripheral blood cells (PBCs) and HRM-PCR was performed in order to investigate the presence of SNPs, and further sequencing analysis was done from selected subjects according to the differences of HRM curves pattern. Statistical analyses were performed using SPSS v16.00. The difference of rs3758539 polymorphism presence between controls and obese patients was significant, but not about rs10882280. We found noticeable association among genetic polymorphisms and biomedical and physical characteristics within investigated population. Our findings suggested that variations in the RBP4 gene were correlated with BMI and polymorphisms more likely could be develop the obesity in our population. Also appraisal of obesity risk factors within each group might be helpful for preventing of obesity initiation and could have a possible role in a predisposition to obesity in the Iranians. Copyright © 2015. Published by Elsevier B.V.
    Gene 02/2015; DOI:10.1016/j.gene.2014.12.071 · 2.08 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Insulin resistance and obesity is influenced by the retinol binding protein 4 (RBP4) adipokine. This study aims to determine if genetic polymorphisms in RBP4 are associated with the risk of coronary artery disease (CAD) in Chinese patients. RBP4 polymorphisms were analyzed by high resolution melting (HRM) analysis in a case-control study of 392 unrelated CAD patients and 368 controls from China. The Gensini score was used to determine the severity of CAD. The genotypic and allelic frequencies of RBP4 single-nucleotide polymorphisms were evaluated for associations with CAD and severity of disease. The A allele frequency was significantly higher in CAD case groups compared to control groups (16.7% vs. 8.8%) at the RBP4 rs7094671 locus. Compared to the G allele, this allele was associated with a higher risk of CAD (OR = 2.07 (1.50-2.84)). Polymorphisms at rs7094671 were found to associate with CAD using either a dominant or recessive model (OR, 95% CI: 1.97, 1.38-2.81; 3.81, 1.53-9.51, respectively). Adjusting for sex, history of smoking, serum TC, TG, LDL-c, and HDL-c, the risk of CAD for carriers remained significantly higher in both dominant and recessive models (OR, 95% CI: 1.68, 1.12-2.51; 2.74, 1.00-7.52, respectively). However, this SNP was not significantly associated with severity of CAD using angiographic scores in multivariable linear regression models (p = 0.373). The RBP4 rs7094671 SNP is associated with CAD; however, our results do not indicate that this locus is associated with clinical severity of CAD or the extent of coronary lesions.
    International Journal of Molecular Sciences 12/2014; 15(12):22309-22319. DOI:10.3390/ijms151222309 · 2.46 Impact Factor